Everything Martin Shkreli said on any show that made the record, most notable first. Each card names its show and opens the statement there.
Shkreli: Zero percent of patients lost access to Daraprim after price hike
“Zero percent.”
Shkreli: BPC-157 is a scam with zero therapeutic value
“BPC-one-five-seven is the biggest scam I've ever seen. It does absolutely nothing. There's no redeemable value to this.”
Shkreli: Drug prices should equal the averted cost of alternative care
“When you do the pricing, I think that the best logical thing to do is pick a price that the alternative care, in other words, a world without this drug, you would forego all those costs for this drug.”
Shkreli: Machines will replace human doctors entirely within 30 years
“There's, if we do our jobs right, there's no such thing as a doctor in 30 years. That every operation, every prescription, every piece of medical advice you ever get from now on comes from a machine and it costs 10 cents.”
Jane Street, Millennium, Citadel bid on Aschenbrenner's liquidated fund assets
“Interestingly, we heard that three firms were bidding on the assets. So Jane Street, Millennium and Citadel were sort of brought in in a closed Close circle sort of late Friday to bid on the remains of the firm.”
Shkreli: Aschenbrenner shopped Anthropic stake at $1.1T valuation for liquidity
“And the rumor is over the weekend, he contacted about 10 parties to place Anthropic in an effort to shore up liquidity, selling the Anthropic stake for allegedly the offer was at a 1.1 trillion equivalent market cap which, you know, I think roughly where it's …”
Shkreli: Peptide craze is driven by psychological issues and institutional distrust
“I'm very concerned about the peptide craze. I think it comes mostly out of psychological issues which we'll discuss. The need for identity, control distrust of institutions, all kinds of things like that are leading to what we're seeing today.”
Shkreli: No clinical trial of BPC-157 will ever work
“I would bet anything. I would bet anything. No trial of BPC would work.”
Shkreli: Mike Bloomberg could be worth $400B-$500B via private equity
“He's taken the Bloomberg dividends and pumped it into a family office that basically Carlisle and all these guys, you know, the Warburg Pincus, all the private equity guys like KKR, They go to him first, and he tosses in, like, five hundred million in each of …”
Shkreli: Quantum computing offers no speedup over classical machines except Shor's algorithm
“The problem is what people don't understand is there are no other algorithms other than Shor's that get you that amazing speed up. So you're better off using the machines we have now. There's no payoff even possible in the future unless we have a new breakthro…”
Shkreli: Quantum computing stocks are worthless shorts with no future market
“The third avenue is of course quantum, and I've spent a lot of time and money on, on quantum computing, and it's just, these stocks are shorts. They're worthless. You know, they, they'll, they'll never be a market for quantum computing.”
Shkreli: Made his wealth in clinical drug development, not price hikes
“A lot of people think that I take medicines and raise prices. Well, this drug was barely in human beings. It had been in like 30 or 50 people. Helped up until that point. And, you know, I made most of my money in, in sort of developments in, in environment on …”
Shkreli: Big Law Firms Easily Secure Rapid Federal Indictments
“And it's not hard if you go to a law firm, you know, like a Cooley, Cleary, Gottlieb, Skadden, Arbs, pick your, Paul Weiss, pick your biggest law firm. You say, hey, we have this guy, he did something bad, you know, look into this. You know, usually you'll get…”
Shkreli: Every insurer covered Daraprim because it was cheaper than ICU stays
“There's not an insurer in the world that didn't cover Daraprim because If you don't pay the 50,000 dollars roughly what Daraprim costs for a whole course, forget per pill, about 50 grand if you end up needing Daraprim. If you don't pay that, you're gonna pay f…”
Shkreli: In the future, humans will marry AI and AI will vote
“You know, probably some of the craziest ones I've made, including include things like they'll, they'll be kind of interspecies marriage between AI and humans. There'll be AI fundamental rights for voting and things like that. That'll kind of reshape society. S…”
Shkreli: Mark Cuban's drug company will not save anyone money
“The, whatever Cuban's doing is not gonna save anybody any money. And it's like, I can make Mark any money either, but this could actually change the curve on healthcare.”
Shkreli: Wall Street funds routinely short failing competitors to accelerate liquidation
“If you don't know somebody has to liquidate, the best thing for you to do, unfortunately, sadly, Darwinian, is to go sell all the positions you have in common, then go start shorting everything they have and it accelerates the sort of downfall as quickly as yo…”
Shkreli: Buyer of Aschenbrenner's public book made $3B-$4B instant markup
“When it came to the public, you know, book, it does sound like you know, the buyer of that book basically got a, from what we were told, a three to four billion dollar Insta markup.”
Shkreli: Total hedge fund AI trade unwind is $500B to $1T
“We're gonna see July numbers very soon here from quite a lot of hedge funds that I think were in the same trade. And so this is not just Leopold's hundred billion gross. It's like that times maybe five or 10.”
Shkreli: Big Tech FOMOed into AI capex as hard as Leopold Aschenbrenner
“You had the hyperscalers and the big companies, they FOMO'd too. They FOMO'd just as hard as Leopold did, right? If not harder. So this isn't just him. It's the whole world collectively saying, fuck, I gotta go all in in AI. And it's, and who had the guts, you…”
Shkreli: Prime brokers rely on Ken Griffin as Wall Street's liquidity backstop
“The prime brokers, the Goldman's and Bank of America's, they do so much business with Citadel, and they've done this before where they know who to go to, just the same way the US government went to Warren Buffett when they wanted to shore up Goldman. They know…”
Shkreli: Pharma avoids peptides as the worst of both worlds
“And in fact, in pharma, you try to avoid peptides because of their inherent weaknesses. You go for small molecules or Really large molecules like antibodies. Peptides are sort of the worst of both worlds.”
Shkreli: Gray-market peptide users are mostly wealthy people in SF and NY
“The people that are take peptides and have these peptide stacks are mostly people in SF, maybe New York. They're very wealthy people. They don't know what the rest of the world looks like. Nobody else in middle, middle America is excited to do this.”
Shkreli: FDA system works and alternate regulatory pathways should not exist
“I think you can shut it down, and then I also think that we have a perfectly great system, which is the normal regulatory body we've had for 60 years. And creating, like I said, a new special ed version of it, For drugs that couldn't quite get on the school bu…”